These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22821339)

  • 1. REST-dependent expression of TRF2 renders non-neuronal cancer cells resistant to DNA damage during oxidative stress.
    Kwon JH; Shin JH; Kim ES; Lee N; Park JY; Koo BS; Hong SM; Park CW; Choi KY
    Int J Cancer; 2013 Feb; 132(4):832-42. PubMed ID: 22821339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine.
    Zhang YW; Zhang ZX; Miao ZH; Ding J
    Mol Pharmacol; 2008 Mar; 73(3):824-32. PubMed ID: 18025071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heregulin, a new regulator of telomere length in human cells.
    Menendez JA; Rubio MA; Campisi J; Lupu R
    Oncotarget; 2015 Nov; 6(37):39422-36. PubMed ID: 26318724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.
    Wu Y; Zacal NJ; Rainbow AJ; Zhu XD
    DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions.
    Nera B; Huang HS; Lai T; Xu L
    Nat Commun; 2015 Dec; 6():10132. PubMed ID: 26640040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells.
    Zhang P; Pazin MJ; Schwartz CM; Becker KG; Wersto RP; Dilley CM; Mattson MP
    Curr Biol; 2008 Oct; 18(19):1489-94. PubMed ID: 18818083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2.
    Opresko PL; Fan J; Danzy S; Wilson DM; Bohr VA
    Nucleic Acids Res; 2005; 33(4):1230-9. PubMed ID: 15731343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion.
    Celli GB; de Lange T
    Nat Cell Biol; 2005 Jul; 7(7):712-8. PubMed ID: 15968270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of the TERRA transcriptome at damaged telomeres.
    Porro A; Feuerhahn S; Delafontaine J; Riethman H; Rougemont J; Lingner J
    Nat Commun; 2014 Oct; 5():5379. PubMed ID: 25359189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC.
    Saha A; Roy S; Kar M; Roy S; Thakur S; Padhi S; Akhter Y; Banerjee B
    Stem Cell Rev Rep; 2018 Dec; 14(6):871-887. PubMed ID: 29872959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NBS1 deficiency promotes genome instability by affecting DNA damage signaling pathway and impairing telomere integrity.
    Hou YY; Toh MT; Wang X
    Cell Biochem Funct; 2012 Apr; 30(3):233-42. PubMed ID: 22161642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons.
    Zhang P; Furukawa K; Opresko PL; Xu X; Bohr VA; Mattson MP
    J Neurochem; 2006 Apr; 97(2):567-81. PubMed ID: 16539655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.
    Muñoz P; Blanco R; Flores JM; Blasco MA
    Nat Genet; 2005 Oct; 37(10):1063-71. PubMed ID: 16142233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
    Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
    Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Mobility Group A2 protects cancer cells against telomere dysfunction.
    Natarajan S; Begum F; Gim J; Wark L; Henderson D; Davie JR; Hombach-Klonisch S; Klonisch T
    Oncotarget; 2016 Mar; 7(11):12761-82. PubMed ID: 26799419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.
    Bai Y; Lathia JD; Zhang P; Flavahan W; Rich JN; Mattson MP
    Glia; 2014 Oct; 62(10):1687-98. PubMed ID: 24909307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review).
    Wang Z; Wu X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage responses in neural cells: Focus on the telomere.
    Zhang P; Dilley C; Mattson MP
    Neuroscience; 2007 Apr; 145(4):1439-48. PubMed ID: 17207936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere repeat binding factor 2 interacts with base excision repair proteins and stimulates DNA synthesis by DNA polymerase beta.
    Muftuoglu M; Wong HK; Imam SZ; Wilson DM; Bohr VA; Opresko PL
    Cancer Res; 2006 Jan; 66(1):113-24. PubMed ID: 16397223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.